HEPION PHARMACEUTICALS, INC. (HEPA) Operating income 2016–2025
HEPION PHARMACEUTICALS, INC. (HEPA) annual operating income history from SEC filings — each fiscal year as reported.
-$4.2MFY2025 · since FY2016: -$20.8M → -$4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.2M | +78.5% |
| FY2024 | -$19.3M | +60.1% |
| FY2023 | -$48.4M | -6.5% |
| FY2022 | -$45.5M | -49.6% |
| FY2021 | -$30.4M | -50.9% |
| FY2020 | -$20.1M | -159.3% |
| FY2019 | -$7.8M | +46.8% |
| FY2018 | -$14.6M | +29.3% |
| FY2017 | -$20.6M | +0.8% |
| FY2016 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice